Bombay Oxygen Investments Regulatory Approval

Other Announcement

Bombay Oxygen Investments Other Announcement

The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is in compliance with SEBI listing regulations.

Annual General Meeting

Bombay Oxygen Investments Annual General Meeting

Bombay Oxygen Investments Limited conducted its 65th Annual General Meeting on August 25, 2026. Shareholders considered the adoption of financial statements and the declaration of a dividend.

Other Announcement

Bombay Oxygen Investments Other Announcement

Bombay Oxygen Investments Ltd will apply to the RBI to voluntarily surrender its NBFC Certificate of Registration. The company expects no material impact on business operations.

Financial Results

Bombay Oxygen Investments Q1 FY27 Results: Net Profit ₹28.5 Cr, Up 17.8% YoY

Bombay Oxygen Investments Ltd reported revenue from operations of ₹33.6 Cr (+16.3% YoY) and net profit of ₹28.5 Cr (+17.8% YoY) for Q1 FY27.

Key figure

Net profit ₹28.5 Cr · +17.8% YoY

Board Meeting Date

Bombay Oxygen Investments Board Meeting Date

Bombay Oxygen Investments Ltd has scheduled a board meeting for August 10, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.

Other Announcement

Bombay Oxygen Investments Other Announcement

The company notified shareholders without registered email addresses on how to access the 65th AGM notice and 2025-26 Annual Report via a provided weblink.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.